Disclosures for "A Phase 1, Open-label, Exploratory, Fixed-sequence, Pharmacokinetic Single Ascending Dose Study of IVL3004 Versus VIVITROL® (Naltrexone) Long-acting Injectable (LAI) in Healthy Subjects"
-
Mr. Seo has nothing to disclose.
-
Mr. Lee has received personal compensation for serving as an employee of Inventage Lab Inc..
-
Ms. Youm has received personal compensation for serving as an employee of Inventagelab.
-
Ms. Kim has nothing to disclose.
-
Mr. Song has nothing to disclose.
-
Mr. Cha has nothing to disclose.
-
Ms. Kim has received personal compensation for serving as an employee of Inventagelab.